William Blair on Dianthus Therapeutics (DNTH): FDA removing ANA criteria 'an incremental positive'

March 26, 2026 10:54 AM

William Blair analyst Mylers Minter reiterated an Outperform rating on Dianthus Therapeutics (NASDAQ: DNTH)The analyst commented, "Dianthus’s update of written ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found